Medulloblastoma is a fast-growing, high-grade tumor that is primarily found in children. While there are currently four recognized subtypes of this tumor, a recent study found there are seven different subgroups of this brain tumor that all have their own characteristics. This highly aggressive tumor type causes approximately 10% of all childhood cancer deaths. Currently, the treatment options available can lead to debilitating side effects such as a lower IQ. These findings may lead to a better understanding of when a gentler form of treatment can be used, and leave the harsher treatments to cases with the worst prognosis, where it’s absolutely necessary.
This new understanding of different subtypes can help to better design a more effective treatment program. These findings can also lead to more clinical trials that may improve diagnosis and treatment of this devastating cancer.
To learn more about this study, read here.